PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 6377829

Extrapancreatic effects of a sulphonylurea. Decrease in xylose absorption by glipizide in type II diabetics.

M Kollind·U Adamson·P E Lins·P Ohlsén
View original source ↗Export metadata ↓

Abstract

The effects of glipizide on the absorption of glucose and d-xylose were studied in six type II diabetics on diet treatment alone. Glipizide was given intravenously (12 micrograms/kg at 0 min) or orally (5 mg at -30 min). Oral glucose (15 g) and xylose (25 g) loads were given at zero time. Glipizide stimulated insulin secretion and reduced glucose and xylose levels significantly with both routes of administration. The suppression of xylose levels lasted longer after oral than after intravenous administration of the drug. It is suggested that part of the influence of glipizide on postprandial glucose levels may represent interference with absorptive mechanisms.

Explore related subjects

Administration, OralAdultAgedBlood GlucoseDiabetes Mellitus, Type 2FemaleGlipizideGlucose Tolerance TestHumansInjections, IntravenousInsulinInsulin SecretionMaleMiddle AgedSulfonylurea CompoundsXyloseClinical TrialJournal ArticleRandomized Controlled TrialResearch Support, Non-U.S. Gov't

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Kollind, U Adamson, P E Lins, P Ohlsén. 1984. Extrapancreatic effects of a sulphonylurea. Decrease in xylose absorption by glipizide in type II diabetics.. https://pubmed.ncbi.nlm.nih.gov/6377829/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1999

The impact of measurement error on the comparison of two treatments using a responder analysis.

Investigators often report results of studies comparing the proportions of subjects who have clinically meaningful responses to various therapeutic regimens. When the outcome variable is a continuous measure this involves dichotomizing the observed response based on a predefined threshold value. The effect of this strategy is examined, paying particular attention to the impact of measurement error on the resulting estimates of treatment effect (difference in the proportion responding). Expressions are obtained for quantifying the magnitude and direction of the resulting bias, and these are illustrated in a study evaluating a pharmaceutical treatment for osteoporosis.

Administration, Oral↗
PubMed1999

Obese mice have higher insulin receptor levels in the hepatocyte cell nucleus following insulin stimulation in vivo with an oral glucose meal.

Internalization of the insulin receptor occurs following insulin binding at the cell surface, which serves to attenuate the insulin signal as well as modulate the number of surface insulin receptors. Obese animals exhibit decreased cell surface insulin receptor number as well as defects in insulin receptor internalization and processing. The insulin receptor may also translocates to the nucleus of hepatocytes and adipocytes following stimulation of cells with insulin. The objective of this study was to determine if insulin receptor trafficking to the hepatocyte cell nucleus could be observed in vivo and whether this process was altered in obese compared to lean mice. Mice were fasted for 12 h to reduce serum insulin to basal levels. Animals were then given an oral meal of glucose to stimulate the binding of insulin to receptor in vivo. Hepatocyte plasma membrane and nuclei were fractionated to purity following the glucose meal. Levels of insulin receptor were determined using insulin binding assays and a Western blotting assay using anti-insulin receptor antibody. As the amount of serum insulin increased following the glucose meal, a corresponding increase in nuclear insulin binding occurred in lean animals but not obese animals (P<0.05). Following the glucose meal, insulin receptor detected in the cell nucleus was increased in obese compared to lean mice (P<0.05). Thus insulin receptor translocation to the nucleus was demonstrated in vivo following a glucose meal in hepatocytes of both lean and obese animals. It is suggested that serum hyperglycemia and hyperinsulinemia in obese mice increased translocation of the insulin receptor to the nucleus.

Administration, Oral↗